Seeking Alpha

Editors' Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.

Executive summary:
  • Wall Street has failed to recognize the disruptive potential (and value) behind Titan Medical's robotic SPORTâ„¢ Surgical System.
  • Titan Medical is targeting an expansive market that has yet to be significantly penetrated by competitor Intuitive Surgical.
  • Titan Medical has a number of value-creating catalysts in 2015.
  • A recent secondary offering provides an appealing entry point for long-term investors.


In part one of this series, I highlighted the woes of Intuitive Surgical's (ISRG) da Vinci System, the benefits of TransEnterix's (OTCQB:TRXC...

Only subscribers can access this article, which is part of the PRO research library covering 3,768 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: